- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
|“Plastic antibodies” that UCI scientists used to stop the spread of bee venom in mice could be designed to combat deadlier toxins and pathogens. Photo by Hoang Xuan Pham / University Communications|
In a breakthrough, UCI chemists create synthetic antibodies that block bee venom
UC Irvine researchers have developed the first "plastic antibodies" successfully employed in live organisms - stopping the spread of bee venom through the bloodstream of mice.
Tiny polymeric particles - just 1/50,000th the width of a human hair - were designed to match and encase melittin, a peptide in bee venom that causes cells to rupture, releasing their contents. Large quantities of melittin can lead to organ failure and death.
The polymer nanoparticles were prepared by "molecular imprinting" a technique similar to plaster casting: UCI chemistry professor Kenneth Shea and project scientist Yu Hoshino linked melittin with small molecules called monomers, solidifying the two into a network of long polymer chains. After the plastic hardened, they removed the melittin, leaving nanoparticles with minuscule melittin-shaped holes.
When injected into mice given high doses of melittin, these precisely imprinted nanoparticles enveloped the matching melittin molecules, "capturing" them before they could disperse and wreak havoc - greatly reducing deaths among the rodents.
"Never before have synthetic antibodies been shown to effectively function in the bloodstream of living animals," Shea says. "This technique could be utilized to make plastic nanoparticles designed to fight more lethal toxins and pathogens."
Takashi Kodama of Stanford University and Hiroyuki Koide, Takeo Urakami, Hiroaki Kanazawa and Naoto Oku of Japan's University of Shizuoka also contributed to the study, published recently in the Journal of the American Chemical Society.
Unlike natural antibodies produced by live organisms and harvested for medical use, synthetic antibodies can be created in laboratories at a lower cost and have a longer shelf life.
"The bloodstream includes a sea of competing molecules - such as proteins, peptides and cells - and presents considerable challenges for the design of nanoparticles," Shea says. "The success of this experiment demonstrates that these challenges can be overcome."
About University of California, Irvine
Founded in 1965, UCI is a top-ranked university dedicated to research, scholarship and community service. Led by Chancellor Michael Drake since 2005, UCI is among the most dynamic campuses in the University of California system, with nearly 28,000 undergraduate and graduate students, 1,100 faculty and 9,000 staff. Orange County’s largest employer, UCI contributes an annual economic impact of $3.9 billion. For more UCI news, visit www.today.uci.edu.
For more information, please click here
Copyright © University of California, IrvineIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
The magic of microbes: ONR engineers innovative research in synthetic biology February 19th, 2016
Chemical cages: New technique advances synthetic biology February 10th, 2016
DNA 'building blocks' pave the way for improved drug delivery January 12th, 2016
Yale researchers’ technology turns wasted heat into power June 27th, 2016